Clinical Trial Update: Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) [Phase 3]

View source ↗

Summary

A Phase 3 parallel-arm trial evaluating AD109 versus placebo in adults with obstructive sleep apnea (LunAIRo) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• AD109

Snippet

Sponsor: Apnimed | Conditions: OSA | Phase 3 | Status: COMPLETED